Myomo insider tax-related sale; Kovelman retains 140,618 shares

Rhea-AI Filing Summary

Myomo, Inc. (MYO) – Form 4 insider transaction

Chief Medical Officer Harry Kovelman reported the automatic sale of 13,054 common shares on 30 June 2025 at $2.19 per share. The transaction is coded “F,” indicating the shares were withheld solely to cover income taxes arising from the vesting of restricted stock units on 28 June 2025. After the sale, Kovelman still beneficially owns 140,618 shares, held directly. No derivative securities were acquired or disposed of, and no additional transactions are disclosed.

The filing appears to be a routine tax-related share withholding rather than a discretionary market sale and does not materially change insider ownership levels.

Insights

Securities Analyst

TL;DR: Routine tax-withholding sale; negligible impact on insider alignment or valuation.

The Form 4 records a mandatory “F” transaction, whereby Harry Kovelman surrendered 13,054 shares (~$28 k) to satisfy tax obligations from RSU vesting. The insider retains 140,618 shares, so his economic exposure remains largely intact. Because the sale is non-discretionary and immaterial to Myomo’s float or governance profile, I view the disclosure as neutral for investors and not market-moving. No new options, warrants, or other derivatives were granted or exercised.

Insider Trade Summary

Net Seller: 13,054 shares

Net Sell 1 txn

Insider Kovelman Harry

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	13,054	$2.19	$29K

Holdings After Transaction: Common Stock — 140,618 shares (Direct)

Footnotes (1)

1. F1. Represents sale of shares on June 30, 2025, solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025.

FAQ

How many Myomo (MYO) shares did the Chief Medical Officer sell on 30 June 2025?

He sold 13,054 shares of common stock at $2.19 each.

Why were the shares sold according to the Form 4 filing?

The shares were sold solely to cover income taxes related to the vesting of restricted stock units on 28 June 2025.

What is Harry Kovelman’s remaining ownership in Myomo after the transaction?

He continues to beneficially own 140,618 shares of Myomo common stock.

What does transaction code "F" represent in this Form 4?

Code "F" indicates a sale of shares to satisfy tax withholding obligations.

Did the filing report any option exercises or other derivative activity?

No. Table II shows no derivative securities were acquired or disposed of.

When did the restricted stock units underlying the tax withholding vest?

The RSUs vested on 28 June 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 07/02/2025 - 08:20 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kovelman Harry

(Last) (First) (Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		F		13,054(1)	D	$2.19	140,618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents sale of shares on June 30, 2025, solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025.

	/s/ David A. Henry, Attorney-in-Fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.